← Leaderboards
Henry W. Murray
Weill Medical College Of Cornell Univ
$6,210,943
Attributed
$6,210,943
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $532.2K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$6,210,943 · 4
By mechanism
R01$5,316,856 · 2
R56$894,087 · 2
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Rosemary Soave$325,825
- Carl F Nathan$43,444,016
Others in their field
Top investigators on “Leishmania Donovani”
- Buddy Ullman · Oregon Health And Science University$12,265,626
- Scott M Landfear · Oregon Health And Science University$7,873,202
- Steven G. Reed · Infectious Disease Research Institute$5,608,676
- Peter C. Melby · University Of Texas Hlth Sci Ctr San Ant$5,284,652
- James H. McKerrow · University Of California San Francisco$5,041,193
- Claudia Abeijon · Detectogen, Inc.$2,498,638
Research focus
Leishmania DonovaniAntimonyMacrophageInterleukin 12Laboratory MouseLinkInfectionAftercareGranulomatousInflammatoryGranulomaKillingsImmuneLeishmaniasisInflammationChemotherapyImmune ResponseImmunoregulationClinical ManagementCancer ImmunotherapyHost DefenseCytokine Network PathwayIn VivoMacrophage Activation
Grant awards (13)
Immunochemotherapy in Visceral Leishmaniasis$482,909
R01 · FY2014 · AI · contact PI
Immunochemotherapy in Visceral Leishmaniasis$453,934
R01 · FY2013 · AI · contact PI
Immunochemotherapy in Visceral Leishmaniasis$482,909
R01 · FY2012 · AI · contact PI
Immunochemotherapy in Visceral Leishmaniasis$484,670
R01 · FY2011 · AI · contact PI
Immunochemotherapy in Visceral Leishmaniasis$487,832
R01 · FY2010 · AI · contact PI
Immunochemotherapy in Visceral Leishmaniasis$473,959
R56 · FY2009 · AI · contact PI
Host Immunoregulation of Response to Antileishmanial Chemotherapy$420,128
R56 · FY2007 · AI · contact PI
HOST IMMUNOREGULATION OF ANTILEISHMANIAL CHEMOTHERAPY$532,191
R01 · FY2005 · AI
HOST IMMUNOREGULATION OF ANTILEISHMANIAL CHEMOTHERAPY$516,690
R01 · FY2004 · AI
HOST IMMUNOREGULATION OF ANTILEISHMANIAL CHEMOTHERAPY$501,642
R01 · FY2003 · AI
HOST IMMUNOREGULATION OF ANTILEISHMANIAL CHEMOTHERAPY$487,031
R01 · FY2002 · AI
HOST IMMUNOREGULATION OF ANTILEISHMANIAL CHEMOTHERAPY$446,041
R01 · FY2001 · AI
HOST IMMUNOREGULATION OF ANTILEISHMANIAL CHEMOTHERAPY$441,007
R01 · FY2000 · AI